<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02963766</url>
  </required_header>
  <id_info>
    <org_study_id>14171</org_study_id>
    <secondary_id>H9X-MC-GBGC</secondary_id>
    <secondary_id>2016-000361-22</secondary_id>
    <nct_id>NCT02963766</nct_id>
  </id_info>
  <brief_title>A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes</brief_title>
  <acronym>AWARD-PEDS</acronym>
  <official_title>A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and&#xD;
      pharmacodynamics of the study drug dulaglutide compared to placebo in pediatric participants&#xD;
      with type 2 diabetes. The study duration is approximately 60 weeks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 29, 2016</start_date>
  <completion_date type="Anticipated">January 7, 2022</completion_date>
  <primary_completion_date type="Actual">June 12, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Hemoglobin A1c (HbA1c)</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in Hemoglobin A1c (HbA1c)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in HbA1c (Individual Doses)</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in HbA1c (Individual Doses)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Fasting Blood Glucose (FBG)</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in Fasting Blood Glucose (FBG)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with HbA1c ≤7.0%</measure>
    <time_frame>Week 26</time_frame>
    <description>Percentage of Participants with HbA1c ≤7.0%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Body Mass Index (BMI)</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in Body Mass Index (BMI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with Self-Reported Events of Hypoglycemia</measure>
    <time_frame>Week 26</time_frame>
    <description>Percentage of Participants with Self-Reported Events of Hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Requiring Rescue for Severe, Persistent Hyperglycemia</measure>
    <time_frame>Week 26</time_frame>
    <description>Percentage of Participants Requiring Rescue for Severe, Persistent Hyperglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adjudicated Pancreatitis</measure>
    <time_frame>Week 26</time_frame>
    <description>Number of Participants with Adjudicated Pancreatitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Pancreatic Enzymes</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in Pancreatic Enzymes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Thyroid Treatment-Emergent Adverse Events</measure>
    <time_frame>Week 26</time_frame>
    <description>Number of Participants with Thyroid Treatment-Emergent Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Serum Calcitonin</measure>
    <time_frame>Baseline, Week 26</time_frame>
    <description>Change from Baseline in Serum Calcitonin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with Allergic, Hypersensitivity and Injection Site Reactions</measure>
    <time_frame>Week 26</time_frame>
    <description>Percentage of Participants with Allergic, Hypersensitivity and Injection Site Reactions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Anti-Dulaglutide Antibodies</measure>
    <time_frame>Baseline through Week 56</time_frame>
    <description>Number of Participants with Anti-Dulaglutide Antibodies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetics (PK): Maximum Concentration (Cmax) of Dulaglutide</measure>
    <time_frame>Week 13 through Week 56</time_frame>
    <description>Pharmacokinetics (PK): Maximum Concentration (Cmax) of Dulaglutide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PK: Area Under the Concentration Time Curve (AUC) of Dulaglutide</measure>
    <time_frame>Week 13 through Week 56</time_frame>
    <description>PK: Area Under the Concentration Time Curve (AUC) of Dulaglutide</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Dose 1 Dulaglutide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dulaglutide given subcutaneously (SC).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dose 2 Dulaglutide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dulaglutide given SC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo given SC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dulaglutide</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>Dose 1 Dulaglutide</arm_group_label>
    <arm_group_label>Dose 2 Dulaglutide</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>LY2189265</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have type 2 diabetes, treated with diet and exercise, with or without metformin and/or&#xD;
             basal insulin. Metformin and/or basal insulin dose must be stable for at least 8 weeks&#xD;
             prior to study screening.&#xD;
&#xD;
          -  Have HbA1c &gt;6.5% to ≤11% at screening visit. If newly diagnosed and not on medicine&#xD;
             for diabetes, HbA1c must be between &gt;6.5 % to ≤9%.&#xD;
&#xD;
          -  Have a BMI (body mass index) &gt;85 percentile for age, gender and body weight ≥50&#xD;
             kilograms (110 pounds).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known type 1 diabetes, or positive GAD65 or IA2 antibodies, or history of diabetic&#xD;
             ketoacidosis or hyperglycemic hyperosmolar syndrome.&#xD;
&#xD;
          -  A history of, or at risk for pancreatitis.&#xD;
&#xD;
          -  Self or family history of Multiple Endocrine Neoplasia (MEN) type 2A or B, thyroid&#xD;
             C-cell hyperplasia or medullary thyroid cancer, or a blood calcitonin result ≥20&#xD;
             picograms per milliliter (pg/ml) at screening.&#xD;
&#xD;
          -  A systolic blood pressure of ≥160 millimeters of mercury (mmHg) or diastolic ≥100&#xD;
             mmHg.&#xD;
&#xD;
          -  Active or treated cancer.&#xD;
&#xD;
          -  A blood disorder where an accurate HbA1c may not be obtainable.&#xD;
&#xD;
          -  A female of childbearing age, sexually active and not on birth control.&#xD;
&#xD;
          -  Pregnant or plan to be pregnant during the study, or breastfeeding.&#xD;
&#xD;
          -  Taking any diabetic medication other than metformin or basal insulin and have not&#xD;
             stopped it 3 months prior to the screening visit (6 weeks for bolus or mealtime&#xD;
             insulin).&#xD;
&#xD;
          -  Have taken oral steroids within the last 60 days or more than 20 days use within the&#xD;
             past year or 1000 micrograms fluticasone propionate per day.&#xD;
&#xD;
          -  Using prescription weight loss medications in the last 30 days, or plan to use.&#xD;
&#xD;
          -  Taking psychiatric medications for depression or illness or attention deficit&#xD;
             hyperactivity disorder (ADHD) if, the doses has changed within the last 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Research Center</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Endocrinology, Diabetes, and Metabolism</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center of Excellence in Diabetes &amp; Endocrinology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95821</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rady Childrens Hospital - San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JC Cabaccan</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Touro University</name>
      <address>
        <city>Vallejo</city>
        <state>California</state>
        <zip>94592</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Center for Endocrinology &amp; Metabolism</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Regional Medical Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808-4124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ECU Pediatric Specialty Care</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Childrens Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital Research Foundation</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multicare Health System</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAMC Institute</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Pesquisas em Diabetes</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90430-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto da Criança com Diabetes</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>91350-200</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Estadual de Diabetes e Endocrinologia</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>20211-340</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital PUC-CAMPINAS</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13034-685</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CPCLIN</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>01228-200</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital da Clinicas da Faculdade de Medicina da USP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clinicas da FMRP</name>
      <address>
        <city>Ribeirão Preto</city>
        <state>São Paulo</state>
        <zip>14051-140</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNIFESP - Escola Paulista de Medicina</name>
      <address>
        <city>São Paulo</city>
        <zip>04022-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518036</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's hospital of Nanjing</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital of Suzhou Medical College</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuxi Children's Hospital</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>No.2 Hospital Affiliated to Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Xian Jiaotong University</name>
      <address>
        <city>Xian</city>
        <state>Shaanxi</state>
        <zip>710004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Third Hospital of Nanchang</name>
      <address>
        <city>Nanchang</city>
        <zip>330009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>201102</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin Bicetre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Robert Debre</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. med. Landers</name>
      <address>
        <city>Mayen</city>
        <state>Rheinland-Pfalz</state>
        <zip>56727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum für klinische Studien</name>
      <address>
        <city>Sankt Ingbert</city>
        <state>Saarland</state>
        <zip>66386</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RED-Institut GmbH</name>
      <address>
        <city>Oldenburg in Holstein</city>
        <state>Schleswig Holstein</state>
        <zip>23758</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heim Pal Gyermekkorhaz</name>
      <address>
        <city>Budapest</city>
        <zip>1089</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Ganga Ram Hospital</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr Jivraj Mehta Smarak Health Foundation Bakeri Medical Research Centre</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380007</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manipal Hospital</name>
      <address>
        <city>Bangalore</city>
        <state>Karmnataka</state>
        <zip>560017</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M S Ramaiah Medical College Hospital</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deenanath Mangeshkar Hospital &amp; Research Centre</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Post Graduate Institute of Medical Education &amp; Research</name>
      <address>
        <city>Chandigarh</city>
        <state>Punjab</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banaras Hindu University - BHU</name>
      <address>
        <city>Varanasi</city>
        <state>Uttar Pradesh</state>
        <zip>221005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Clinic</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700017</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Apollo Gleneagles Hospitals Kolkata</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Pharma Professional Research, S.A. de C.V.</name>
      <address>
        <city>Mexico City</city>
        <state>Federal District</state>
        <zip>03810</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Inv. Medica de Occidente, SC</name>
      <address>
        <city>Zapopan</city>
        <state>Jalisco</state>
        <zip>45116</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Medico San Francisco</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64710</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cli-nica Hospital Cemain</name>
      <address>
        <city>Tampico</city>
        <state>Tamaulipas</state>
        <zip>89249</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Angeles Puebla</name>
      <address>
        <city>Puebla</city>
        <zip>72190</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arke Estudios Clinicos S.A. de C.V.</name>
      <address>
        <city>Veracruz</city>
        <zip>91910</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Diabetes y Endocrinologia Pediatrica de PR</name>
      <address>
        <city>Bayamon</city>
        <zip>00959</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Saud University Hospital</name>
      <address>
        <city>Riyadh</city>
        <zip>11472</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Salman bin Abdulaziz Hospital - Diabetic Center</name>
      <address>
        <city>Riyadh</city>
        <zip>12769</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara University Medicine Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Mamak</state>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sami Ulus Education &amp; Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06080</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duzce University Medical Faculty</name>
      <address>
        <city>Duzce</city>
        <zip>81620</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ondokuz Mayis University Medical Faculty</name>
      <address>
        <city>Samsun</city>
        <zip>55139</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alder Hey Children's Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>Lancashire</state>
        <zip>L14 5AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>China</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Mexico</country>
    <country>Puerto Rico</country>
    <country>Saudi Arabia</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <link>
    <url>https://trials.lillytrialguide.com/en-US/trial/5RwyJT8t9uI0ISG4U4SEu0</url>
    <description>A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes (AWARD-PEDS)</description>
  </link>
  <verification_date>June 15, 2021</verification_date>
  <study_first_submitted>November 10, 2016</study_first_submitted>
  <study_first_submitted_qc>November 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2016</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dulaglutide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data are available 6 months after the primary publication and approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.</ipd_time_frame>
    <ipd_access_criteria>A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.</ipd_access_criteria>
    <ipd_url>https://www.vivli.org/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

